Serum levels of adiponectin are extremely well studied and it has been very convincingly demonstrated that in obesity and its related disorders adiponectin serum levels are reduced [4,25], while certain drugs such as thiazolidinediones/PPARγ activation induce adiponectin [26]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.